Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for ZUSAMMENSETZUNGEN ENTHALTEND EIN VIP-ELP FUSIONSPROTEIN ZUR VERWENDUNG IN DER BEHANDLUNG VON MUKOVISZIDOSE
Details for 2015789718
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2015789718
Title / Product Name
ZUSAMMENSETZUNGEN ENTHALTEND EIN VIP-ELP FUSIONSPROTEIN ZUR VERWENDUNG IN DER BEHANDLUNG VON MUKOVISZIDOSE
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2015789718
EP Publication Number
3139949
E-Number
1295016
Language
EN
PCT Number
US15029926
Publication Date
15.03.2017 A
29.07.2020 B1
Registration Date
29.07.2020
AT Publication Date
15.08.2020
Application Date
08.05.2015
Registration Number
-
Priorities
08.05.2014
US
201461990425 P
IPC
A61K 38/22 20060101AFI20171023BHEP
Maximum Duration of Protection
08.05.2035
Owner
Phasebio Pharmaceuticals, Inc.
One Great Valley Parkway Suite 30
Malvern, Pennsylvania 19355-1423
US
Representative
No representatives present
Inventor
ARNOLD, Susan
c/o PHASEBIO PHARMACEUTICALS INC. One Great Valley Parkway Suite 30
Malvern, Oregon 19355-1423
US
BALLANCE, David James
c/o PHASEBIO PHARMACEUTICALS INC. One Great Valley Parkway Suite 30
Malvern, Pennsylvania 19355-1423
US